UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy

Clinica chimica acta, 2013-10, Vol.425, p.206-211

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic relevance of plasma DNA and DNA integrity for breast cancer

Tumor biology, 2014-02, Vol.35 (2), p.1183-1191

2014

Link zum Volltext

Verfügbarkeit prüfen

Methods for isolation of cell-free plasma DNA strongly affect DNA yield

Clinica chimica acta, 2011-11, Vol.412 (23-24), p.2085-2088

2011

Link zum Volltext

Verfügbarkeit prüfen

Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study

Frontiers in pharmacology, 2019-04, Vol.10, p.410-410

2019

Link zum Volltext

Verfügbarkeit prüfen

The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy

Breast cancer research : BCR, 2023-03, Vol.25 (1), p.32-32, Article 32

2023

Link zum Volltext

Verfügbarkeit prüfen

Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer

International journal of clinical pharmacology and therapeutics, 2013-01, Vol.51 (1), p.59

2013

Link zum Volltext

Verfügbarkeit prüfen

Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report

International journal of hyperthermia, 2020-01, Vol.37 (1), p.55-65

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study

International journal of cancer, 2024-07, Vol.155 (1), p.128-138

2024

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study

Acta oncologica, 2021-01, Vol.60 (1), p.24-27

2021

Link zum Volltext

Verfügbarkeit prüfen

Compatibility of Biosimilar Filgrastim with Cytotoxic Chemotherapy during the Treatment of Malignant Diseases (VENICE): A Prospective, Multicenter, Non-Interventional, Longitudinal Study

Advances in therapy, 2016-11, Vol.33 (11), p.1983-2000

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO

Clinical breast cancer, 2020-06, Vol.20 (3), p.e315-e326

2020

Link zum Volltext

Verfügbarkeit prüfen

Isolation of human MHC class II‐restricted T cell receptors from the autologous T‐cell repertoire with potent anti‐leukaemic reactivity

Immunology, 2012-11, Vol.137 (3), p.226-238

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract GS3-01: Investigating denosumab as an add-on treatment to neoadjuvant chemotherapy and two different nab-paclitaxel schedules in a 2x2 design in primary breast cancer - First results of the GeparX study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS3-01-GS3-01

2020

Link zum Volltext

Verfügbarkeit prüfen

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

BMC cancer, 2014-12, Vol.14 (1), p.897-897, Article 897

2014

Link zum Volltext

Verfügbarkeit prüfen

RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial

Clinical cancer research, 2023-11, Vol.29 (22), p.4606

2023

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies against p53 are not increased in human ascites and pleural effusions

Cancer Immunology, Immunotherapy, 1996-03, Vol.42 (3), p.200-201

1996

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Efficacy of Known P-Glycoprotein Modulators Compared to Droloxifene E and Z: Studies on a Human T-Cell Leukemia Cell Line and their Resistant Variants

Leukemia & lymphoma, 1998, Vol.31 (5-6), p.589-597

1998

Link zum Volltext

Verfügbarkeit prüfen

Chronische myeloische Leukämie - Therapie

Deutsche medizinische Wochenschrift, 2002-12, Vol.127 (49), p.2621-2624

2002

Link zum Volltext

Verfügbarkeit prüfen

Chronische myeloische Leukämie - Pathophysiologie und Diagnostik

Deutsche medizinische Wochenschrift, 2002-12, Vol.127 (49), p.2618-2620

2002

Link zum Volltext

Verfügbarkeit prüfen

Chronische myeloische Leukämie - Der konkrete Fall

Deutsche medizinische Wochenschrift, 2002-12, Vol.127 (49), p.2617-2617

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(14)
Oncology
(12)
Female
(9)
Adult
(6)
Middle Aged
(6)
Aged
(5)
Breast Cancer
(5)
Chemotherapy
(5)
Breast Neoplasms - Drug Therapy
(4)
Breast Neoplasms - Pathology
(4)
Dna - Blood
(4)
Metastasis
(4)
Neoadjuvant Chemotherapy
(4)
Prognosis
(4)
Treatment Outcome
(4)
Aged, 80 And Over
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Breast Neoplasms - Blood
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy

Diagnostic relevance of plasma DNA and DNA integrity for breast cancer

Methods for isolation of cell-free plasma DNA strongly affect DNA yield

Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study

The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy

Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report

Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study

Compatibility of Biosimilar Filgrastim with Cytotoxic Chemotherapy during the Treatment of Malignant Diseases (VENICE): A Prospective, Multicenter, Non-Interventional, Longitudinal Study

Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO

Isolation of human MHC class II‐restricted T cell receptors from the autologous T‐cell repertoire with potent anti‐leukaemic reactivity

Abstract GS3-01: Investigating denosumab as an add-on treatment to neoadjuvant chemotherapy and two different nab-paclitaxel schedules in a 2x2 design in primary breast cancer - First results of the GeparX study

Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial

Autoantibodies against p53 are not increased in human ascites and pleural effusions

In Vitro Efficacy of Known P-Glycoprotein Modulators Compared to Droloxifene E and Z: Studies on a Human T-Cell Leukemia Cell Line and their Resistant Variants

Chronische myeloische Leukämie - Therapie

Chronische myeloische Leukämie - Pathophysiologie und Diagnostik

Chronische myeloische Leukämie - Der konkrete Fall

Suchergebnisse filtern